Posts

Artificial Intelligence in Prostate Cancer

Image
Introducing the AI Oncology Revolution with Dr. Arturo Loaiza-Bonilla - YouTube Promise, Peril, and Patient Protection in the Age of Clinical AI Bottom Line Up Front (BLUF) Artificial intelligence is transforming prostate cancer care—from diagnosis to treatment—with demonstrated improvements in accuracy and efficiency. The FDA has approved the first AI tool for prostate pathology. Clinical research published in 2024–2025 shows dramatic benefits: earlier detection, better risk assessment, and more personalized treatment. However, AI also introduces two critical vulnerabilities that threaten patient safety and privacy: (1) HIPAA breaches via unsanctioned AI tools and vendor negligence, and (2) AI hallucinations that fabricate medical information, leading to misdiagnosis and delayed care. For patients and clinicians, this means AI is not "plug and play"—it requires rigorous governance, independent verification,...
Post a Comment
Read more

The Other Patient: Care for the Caregivers

Image
Informed Prostate Cancer Support Group (IPCSG) Newsletter  |  April 2026 What Our Partners and Caregivers Carry on This Roller Coaster A close look at the hidden burden borne by spouses and care partners across surgery, ADT, radiation, imaging, and theranostics   Prepared for the IPCSG Community  |  April 2026 Bottom Line Up Front (BLUF) When a man is diagnosed with prostate cancer and embarks on treatment — whether surgery, radiation, androgen deprivation therapy (ADT), PSMA imaging, or the newest theranostics — his spouse or care partner shoulders a second, often invisible, patient journey alongside him. Research consistently shows that partners experience rates of anxiety and depression equal to or greater than patients, sacrifice thousands of hours of work and personal time, suffer significant sexual and intimacy losses, and receive far less clinical attention th...
Post a Comment
Read more

Genetic Testing for Prostate Cancer:

Image
  What tools do men need to make an informed decision about germline genetic testing for prostate cancer: A qualitative and survey study | medRxiv What Every Patient Should Know in 2026 A new wave of guidelines, approved therapies, and patient-centered tools is making germline genetic testing a standard part of prostate cancer care — but most men still haven't been tested. Here's what you need to know. Bottom Line Up Front (BLUF) Germline genetic testing — a blood or saliva test that looks for inherited gene changes — has become a cornerstone of prostate cancer care in 2025–2026. Both ASCO and NCCN now recommend it broadly for men with metastatic, high-risk, or locally advanced disease, and for men with relevant family histories. Knowing your genetic status can guide which treatments will work best for you (including PARP inhibitors like olaparib and rucaparib), alert your sons, brothers, and other relatives to start screening earlier, and reve...
Post a Comment
Read more